Jazz Pharma, CoLucid Spike Premarket, Plus Other Biotech Movers


CoLucid Pharmaceuticals led the biotech stocks Wednesday morning in premarket moving, seeing its share price skyrocket more than 30% ahead of market's open. CoLucid, which is developing a pill to treat migraine headaches, is being acquired by Eli Lilly for $960 million in cash.



from Biotech News